A supramolecular synthon-based crystal engineering approach was adopted to design an exceptional class of gelators utilizing simple organic salt formation between monocarboxylic acid drugs (NSAIDs and 5-fluorouracil acetic acid or 5F) and N,N′-bis(4-pyridyl)urea (4U) reacted in 1:1 and 2:1 molar ratio, respectively. Among 14 salts, 6 turned to be aqueous gelators. In fact, 2_5F·4U, an organic salt formed by the combination of two molecules of 5F and one molecule of 4U having molecular weight <300 produced a pure water gel. Single-crystal X-ray diffraction performed with six salts indicated the presence of 1D H-bonding networks and the characteristic supramolecular synthons as envisaged. Several in vitro assays showed that the salt 2_5F·4U effectively induced apoptotic death in skin melanoma B16–F10 cells. Along with excellent rheoreversibility, the 2_5F·4U hydrogel could be shaped into a highly stable shape-sustaining translucent patch which could be placed on an adhesive tape for topical applications. The biological studies and material properties proved the 2_5F·4U hydrogel to be a potential topically applicable anticancer agent, highlighting the merits of the proposed rationale of designing supramolecular therapeutic hydrogels reported herein.
No takes yet. Share an insight, caveat, or question.
Chakraborty et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: